Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-31

Clinical Trial Update: SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type

View source ↗

Summary

The document reports a not-yet-recruiting clinical trial evaluating a SERS-based serum spectral screening method for lung cancer type differentiation. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Lung Cancer, Non-Small Cell, Lung Cancer Small Cell Lung Cancer (SCLC) | Status: NOT_YET_RECRUITING